Cardiff Oncology Earnings Preview
Portfolio Pulse from Benzinga Insights
Cardiff Oncology (NASDAQ:CRDF) is scheduled to release its quarterly earnings report on Thursday, 2024-02-29, with analysts expecting an EPS of $-0.28. The company's past earnings performance shows a mix of beats and misses, with the stock price reacting variably. Shares are currently trading at $1.78, up 6.97% over the last 52 weeks. Investors will be keenly watching for not just the earnings outcome but also the company's guidance for future growth.

February 28, 2024 | 7:01 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Cardiff Oncology is expected to report an EPS of $-0.28 for the quarter. Historical performance shows variable stock price reactions to earnings reports. Currently trading at $1.78, the stock has gained 6.97% over the past year.
Given the mixed historical earnings performance and the current positive year-to-date stock performance, the short-term impact of the upcoming earnings report on CRDF's stock price is uncertain. The guidance provided by the company will likely play a crucial role in determining the stock's direction. The importance rating is high due to the potential for significant stock movement post-earnings, but the confidence in predicting the direction of the movement is moderate due to the variability in past reactions.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 100